LEVOCETIRIZINA TERAPIA 5mg film-coated tablets
levocetirizine Indicated for: allergic rhinitis; urticaria
letter L · page 28
levocetirizine Indicated for: allergic rhinitis; urticaria
levodopa + benserazide Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + benserazide Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + benserazide Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives